메뉴 건너뛰기




Volumn 99, Issue 2, 1997, Pages 300-305

Poliomyelitis prevention: Recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

EID: 0030889783     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.99.2.300     Document Type: Review
Times cited : (40)

References (29)
  • 1
    • 0026527532 scopus 로고
    • Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease
    • Strebel PM, Sutter RW, Cochi SL, et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis. 1992;14:568-579
    • (1992) Clin Infect Dis. , vol.14 , pp. 568-579
    • Strebel, P.M.1    Sutter, R.W.2    Cochi, S.L.3
  • 2
    • 0027117859 scopus 로고
    • Update. Eradication of paralytic poliomyelitis in the Americas
    • Centers for Disease Control and Prevention. Update. Eradication of paralytic poliomyelitis in the Americas. MMWR. 1992;41:681-683
    • (1992) MMWR , vol.41 , pp. 681-683
  • 3
    • 0028767688 scopus 로고
    • Certification of poliomyelitis eradication - The Americas, 1994
    • Centers for Disease Control and Prevention. Certification of poliomyelitis eradication - the Americas, 1994. MMWR. 1994;43:720-722
    • (1994) MMWR , vol.43 , pp. 720-722
  • 4
    • 0029639787 scopus 로고
    • Expanded programme on immunization: Statement on poliomyelitis eradication
    • World Health Organization. Expanded programme on immunization: statement on poliomyelitis eradication. Weekly Epidemiol Record. 1995; 70:345-347
    • (1995) Weekly Epidemiol Record. , vol.70 , pp. 345-347
  • 5
    • 0029064733 scopus 로고
    • To conquer poliomyelitis forever
    • Cochi SL, Hull HF, Ward NA. To conquer poliomyelitis forever. Lancet. 1995;345:1589-1590
    • (1995) Lancet , vol.345 , pp. 1589-1590
    • Cochi, S.L.1    Hull, H.F.2    Ward, N.A.3
  • 6
    • 1842352362 scopus 로고    scopus 로고
    • Poliomyelitis prevention in the United States: Introduction of sequential schedule of inactivated poliovirus vaccine (IPV) followed by OPV
    • Recommendations of the Advisory Committee on Immunization Practices (ACIP). In press
    • Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: introduction of sequential schedule of inactivated poliovirus vaccine (IPV) followed by OPV. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. In press
    • MMWR
  • 7
    • 1842382243 scopus 로고
    • Washington, DC: National Academy of Sciences
    • Institute of Medicine. Eradication of Poliomyelitis Vaccines. Washington, DC: National Academy of Sciences; 1977
    • (1977) Eradication of Poliomyelitis Vaccines
  • 9
    • 1842395881 scopus 로고
    • Red Book Committee considers increased IPV use
    • Peter G, Halsey NA. Red Book Committee considers increased IPV use. AAP News. 1995;10:13
    • (1995) AAP News , vol.10 , pp. 13
    • Peter, G.1    Halsey, N.A.2
  • 10
    • 0028143055 scopus 로고
    • Administration of the third dose of oral poliomyelitis vaccine at 6 to 18 months of age
    • Committee on Infectious Diseases, American Academy of Pediatrics. Administration of the third dose of oral poliomyelitis vaccine at 6 to 18 months of age. Pediatrics. 1994;94:774-775
    • (1994) Pediatrics , vol.94 , pp. 774-775
  • 11
    • 0029948751 scopus 로고    scopus 로고
    • Seroprevalence of antibody against poliovirus in inner-city preschool children
    • Chen RT, Hausinger S, Dajani AS, et al. Seroprevalence of antibody against poliovirus in inner-city preschool children. JAMA. 1996;275: 1639-1645
    • (1996) JAMA , vol.275 , pp. 1639-1645
    • Chen, R.T.1    Hausinger, S.2    Dajani, A.S.3
  • 12
    • 0003148342 scopus 로고
    • Polio vaccines
    • Stratton KR, Howe CJ, Johnston RB Jr, eds. Washington, DC: National Academy Press
    • Institute of Medicine. Polio vaccines. In: Stratton KR, Howe CJ, Johnston RB Jr, eds. Adverse Events Associated With Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: National Academy Press; 1994: 187-210
    • (1994) Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality , pp. 187-210
  • 13
    • 0003179002 scopus 로고    scopus 로고
    • Recommendations of the Advisory Committee on Immunization Practices (ACIP): Updated sections on vaccine side effects, adverse reactions, contraindications, and precautions
    • In press
    • Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): updated sections on vaccine side effects, adverse reactions, contraindications, and precautions. MMWR. In press
    • MMWR
  • 14
    • 0028053039 scopus 로고
    • Epidemiology of Guillain-Barré E9 syndrome in children: Relationship of oral polio vaccine administration to occurrence
    • Rantala H, Cherry JD, Shields WD, Uhari M. Epidemiology of Guillain-Barré E9 syndrome in children: relationship of oral polio vaccine administration to occurrence. J Pediatr. 1994;124:220-223
    • (1994) J Pediatr. , vol.124 , pp. 220-223
    • Rantala, H.1    Cherry, J.D.2    Shields, W.D.3    Uhari, M.4
  • 15
    • 0028272455 scopus 로고
    • Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991: Implications for estimating the risk of vaccine-associated disease
    • Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991: implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med. 1994;148:479-485
    • (1994) Arch Pediatr Adolesc Med. , vol.148 , pp. 479-485
    • Prevots, D.R.1    Sutter, R.W.2    Strebel, P.M.3    Weibel, R.E.4    Cochi, S.L.5
  • 16
    • 1842386146 scopus 로고
    • Vaccine-associated paralytic poliomyelitis among immunodeficient persons
    • Sutter RW, Prevots DR. Vaccine-associated paralytic poliomyelitis among immunodeficient persons. Infect Med. 1994;426:429-430,435-438
    • (1994) Infect Med. , vol.426 , pp. 429-430
    • Sutter, R.W.1    Prevots, D.R.2
  • 17
    • 1842394906 scopus 로고
    • History and Current Status
    • Howe CJ, Johnston RB, eds. Washington, DC: National Academy Press
    • Institute of Medicine. History and Current Status. In: Howe CJ, Johnston RB, eds. Options for Poliomyelitis Vaccination in the United States. Washington, DC: National Academy Press; 1995:3-13
    • (1995) Options for Poliomyelitis Vaccination in the United States , pp. 3-13
  • 18
    • 0023766078 scopus 로고
    • Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines
    • McBean AM, Thoms ML, Albrecht P, et al. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. Am J Epidemiol. 1988;128:615-628
    • (1988) Am J Epidemiol. , vol.128 , pp. 615-628
    • McBean, A.M.1    Thoms, M.L.2    Albrecht, P.3
  • 19
    • 0025203093 scopus 로고
    • Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: Systemic and local immune responses
    • Faden H, Modlin JF, Thoms ML, McBean AM, Ferdon MB, Ogra PL. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses. J Infect Dis. 1990; 162:1291-1297
    • (1990) J Infect Dis. , vol.162 , pp. 1291-1297
    • Faden, H.1    Modlin, J.F.2    Thoms, M.L.3    McBean, A.M.4    Ferdon, M.B.5    Ogra, P.L.6
  • 20
    • 0342809466 scopus 로고    scopus 로고
    • Humoral and mucosal immunity in infants induced by three sequential IPV-OPV immunization schedules
    • In press
    • Modlin JF, Halsey NA, Thoms ML, Meschievitz CK, Patriarca PA, Baltimore Area Polio Vaccine Study Group. Humoral and mucosal immunity in infants induced by three sequential IPV-OPV immunization schedules. J Infect Dis. In press
    • J Infect Dis.
    • Modlin, J.F.1    Halsey, N.A.2    Thoms, M.L.3    Meschievitz, C.K.4    Patriarca, P.A.5
  • 21
    • 0027169662 scopus 로고
    • Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccine
    • Faden H, Duffy L, Sun M, Shuff C. Long-term immunity to poliovirus in children immunized with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccine. J Infect Dis. 1993;168:452-454
    • (1993) J Infect Dis. , vol.168 , pp. 452-454
    • Faden, H.1    Duffy, L.2    Sun, M.3    Shuff, C.4
  • 22
    • 0023546185 scopus 로고
    • A study of sero-immunity that has protected the Swedish population against poliomyelitis for 25 years
    • Bottiger M. A study of sero-immunity that has protected the Swedish population against poliomyelitis for 25 years. Scand J Infect Dis. 1987; 19:595-601
    • (1987) Scand J Infect Dis. , vol.19 , pp. 595-601
    • Bottiger, M.1
  • 24
    • 0028825028 scopus 로고
    • Inactivated polio vaccine for the United States: A missed vaccination opportunity
    • Plotkin SA. Inactivated polio vaccine for the United States: a missed vaccination opportunity. Pediatr Infect Dis J. 1995;14:835-839
    • (1995) Pediatr Infect Dis J. , vol.14 , pp. 835-839
    • Plotkin, S.A.1
  • 25
    • 0023266662 scopus 로고
    • Rationale for the sequential use of inactivated poliovirus vaccine and live attenuated poliovirus vaccine for routine poliomyelitis immunization in the United States
    • McBean AM, Modlin JF. Rationale for the sequential use of inactivated poliovirus vaccine and live attenuated poliovirus vaccine for routine poliomyelitis immunization in the United States. Pediatr Infect Dis J. 1987;6:881-887
    • (1987) Pediatr Infect Dis J. , vol.6 , pp. 881-887
    • McBean, A.M.1    Modlin, J.F.2
  • 26
    • 0027491318 scopus 로고
    • Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine
    • Abraham R, Minor P, Dunn G, Modlin JF, Ogra PL. Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine. J Infect Dis. 1993;168:1105-1109
    • (1993) J Infect Dis. , vol.168 , pp. 1105-1109
    • Abraham, R.1    Minor, P.2    Dunn, G.3    Modlin, J.F.4    Ogra, P.L.5
  • 27
    • 0025945473 scopus 로고
    • Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines
    • Ogra PL, Faden HS, Abraham R, Duffy LC, Sun M, Minor PD. Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. J Infect Dis. 1991;164:191-194
    • (1991) J Infect Dis. , vol.164 , pp. 191-194
    • Ogra, P.L.1    Faden, H.S.2    Abraham, R.3    Duffy, L.C.4    Sun, M.5    Minor, P.D.6
  • 28
    • 0030175812 scopus 로고    scopus 로고
    • Inactivated poliovirus vaccine: Past and present experience
    • Murdin AD, Barreto L, Plotkin S. Inactivated poliovirus vaccine: past and present experience. Vaccine. 1996;14:735-746
    • (1996) Vaccine , vol.14 , pp. 735-746
    • Murdin, A.D.1    Barreto, L.2    Plotkin, S.3
  • 29
    • 1842385174 scopus 로고    scopus 로고
    • Poliovirus infection
    • Peter G, ed. Elk Grove Village, IL: American Academy of Pediatrics. In press
    • American Academy of Pediatrics. Poliovirus infection. In: Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics. In press
    • 1997 Red Book: Report of the Committee on Infectious Diseases. 24th Ed.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.